Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
6.2M
-
Shares change
-
-120K
-
Total reported value, excl. options
-
$5.93M
-
Value change
-
-$120K
-
Put/Call ratio
-
0.02
-
Number of buys
-
4
-
Number of sells
-
-8
-
Price
-
$0.95
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q2 2023
26 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q2 2023.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.2M shares
of 386M outstanding shares and own 1.61% of the company stock.
Largest 10 shareholders include HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (1.72M shares), STONEHILL CAPITAL MANAGEMENT LLC (1.51M shares), RENAISSANCE TECHNOLOGIES LLC (1.37M shares), ACADIAN ASSET MANAGEMENT LLC (728K shares), Whitefort Capital Management, LP (410K shares), Aristides Capital LLC (162K shares), Cambridge Investment Research Advisors, Inc. (111K shares), MORGAN STANLEY (38.2K shares), CITADEL ADVISORS LLC (37.6K shares), and WEALTHSOURCE PARTNERS, LLC (30.2K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.